Anti-Arrhythmia Agents/therapeutic use; Autonomic Denervation; Cardiac Pacing, Artificial; Catheter Ablation; Extracorporeal Membrane Oxygenation; Tachycardia, Ventricular/therapy; Ventricular Fibrillation/therapy; Action Potentials/drug effects; Anti-Arrhythmia Agents/adverse effects; Autonomic Denervation/adverse effects; Autonomic Denervation/mortality; Cardiac Pacing, Artificial/adverse effects; Cardiac Pacing, Artificial/mortality; Catheter Ablation/adverse effects; Catheter Ablation/mortality; Clinical Decision-Making; Decision Support Techniques; Extracorporeal Membrane Oxygenation/adverse effects; Extracorporeal Membrane Oxygenation/mortality; Heart Conduction System/drug effects; Heart Conduction System/physiopathology; Heart Conduction System/surgery; Heart Rate/drug effects; Humans; Pacemaker, Artificial; Recurrence; Risk Assessment; Risk Factors; Tachycardia, Ventricular/diagnosis; Tachycardia, Ventricular/mortality; Tachycardia, Ventricular/physiopathology; Treatment Outcome; Ventricular Fibrillation/diagnosis; Ventricular Fibrillation/mortality; Ventricular Fibrillation/physiopathology

Antiarrhythmic Drugs; Cardiac Arrhythmia; Catheter Ablation; Electrical Storm; Ventricular Tachycardia